From June 6-7, 2019, over 70 clinical trial supply professionals from all over Europe met at the Parexel Academy in Berlin for the annual symposium of the Investigational Products Community of Practice (IP CoP) of the International Society for Pharmaceutical Engineering (ISPE). Invited by Parexel Academy’s Senior Director and IPCoP steering committee chair, Andrea Zobel, this event was organized and managed by the 20+ senior directors and heads of clinical supply as well as representatives from key suppliers to provide the ultimate platform for networking.

If you need a tailored training for your company visit our Industry Seminars page to find out how Parexel Academy can help you to design the best training package.

ISPE participants in Berlin

ISPE IP Europe 2019

Parexel Academy hosts ISPE CoP Investigational Products Symposium 2019 “Prepare for the Future of your Clinical Supply Chain”

Delegates included pharma companies Sanofi, Bayer, CSL Behring, Daichii Sankyo, Novartis, AstraZeneca and Boehringer-Ingelheim, Contract Manufacturing Organizations (CMOs), clinical supply information technology vendors, homecare vendors and couriers.

The two-day event comprised a mix of interactive workshops, presentations and discussions, giving participants the opportunity to broaden their horizons, share best practice, debate challenges and explore innovative solutions. It also provided an excellent opportunity to showcase Parexel’s expertise and Parexel Academy’s training talent.

Stimulating presentations reflected the Patient, Investigator and Clinical Supply Pharma Industry perspective. Facilitated by leading industry experts, new insights into driving trends and technology were discussed in interactive break-out sessions.

In keeping with Parexel’s approach of putting the patient at the heart of all we do, the symposium kicked off with the results of a patient survey presented by Esther Sadler-Williams. The patient is generally considered the ‘weakest link’ in the clinical supply chain, so what can be done to improve patient compliance and IMP control? This was a refreshing look at the challenges of IMP supply from a patient and site perspective.

The perspective of the clinical site was presented in an interactive discussion with the clinical site pharmacist Stefan Dittmann, Hubertus Pharmacy, and the experienced CRA and Academy trainer Claudia Richter.

Tracking is a perpetual challenge in clinical trial supply. Sylvain Alberola, Head of Sanofi’s Industrial Development Clinical Supply Chain put an eloquent and convincing case for GS1, a global standardized method of IMP kit identification.

In three parallel workshops, patient-centric clinical supply, eLabeling and Universal Language approach were discussed, followed on the second day by a technology workshop with forecasting/simulation, smart package, smart label, in-package logger presentations, and GCP and IRT system training. The symposium was rounded off by visits to Parexel’s Early Phase Unit and Hubertus Apotheke in Berlin.

Parexel Academy was honored to have the opportunity to host this event for the second year in succession, to gain insights from attendees, and contribute the expertise and experience of our clinical trial supply and logistics experts and Parexel Academy team. The symposium was such a success that plans are already underway for Parexel Academy to host next year’s conference – proof that all good things come in threes and that the Academy can ‘deliver the goods’!